Breast Cancer
Featured Article
Although outcomes are not negatively impacted, researchers recently examined older women with breast cancer, aged between 77 and 81 years, and found that many of them do not receive treatment that fully conforms to National Comprehensive Cancer Network recommendations,.
Compared with those with private insurance, participants in breast cancer clinical trials with Medicare, Medicaid, or other government insurance were less likely to complete trials and had a lower…
Most clinical trials supporting US Food and Drug Administration approval of drugs for metastatic breast cancer over the past 13 years did not meet thresholds for substantial clinical benefit on two…